Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory Diseases

Malik Bisserier, Xiao-Qing Sun, Shahood Fazal, Irene C. Turnbull, S. bastien Bonnet, Lahouaria Hadri

Research output: Contribution to journalReview articleAcademicpeer-review

7 Citations (Scopus)


Over the past decades, a better understanding of the genetic and molecular alterations un-derlying several respiratory diseases has encouraged the development of new therapeutic strategies. Gene therapy offers new therapeutic alternatives for inherited and acquired diseases by delivering exogenous genetic materials into cells or tissues to restore physiological protein expression and/or ac-tivity. In this review, we review (1) different types of viral and non-viral vectors as well as gene-editing techniques; and (2) the application of gene therapy for the treatment of respiratory diseases and disorders, including pulmonary arterial hypertension, idiopathic pulmonary fibrosis, cystic fibrosis, asthma, alpha-1 antitrypsin deficiency, chronic obstructive pulmonary disease, non-small-cell lung cancer, and COVID-19. Further, we also provide specific examples of lung-targeted therapies and discuss the major limitations of gene therapy.
Original languageEnglish
Article number984
Issue number6
Publication statusPublished - 12 Mar 2022


  • AAV
  • COPD
  • COVID-19
  • Gene editing
  • Gene therapy
  • Lung fibrosis
  • Nanoparticles
  • Pulmonary hypertension
  • Respiratory disease
  • Treatment

Cite this